Bafna Pharmaceuticals Statistics

Total Valuation

NSE:BAFNAPH has a market cap or net worth of INR 1.70 billion. The enterprise value is 1.88 billion.

Market Cap	1.70B
Enterprise Value	1.88B

Important Dates

The next estimated earnings date is Friday, May 30, 2025.

Earnings Date	May 30, 2025
Ex-Dividend Date	n/a

Share Statistics

NSE:BAFNAPH has 23.66 million shares outstanding. The number of shares has increased by 0.39% in one year.

Current Share Class	n/a
Shares Outstanding	23.66M
Shares Change (YoY)	+0.39%
Shares Change (QoQ)	+0.48%
Owned by Insiders (%)	0.61%
Owned by Institutions (%)	4.11%
Float	5.87M

Valuation Ratios

The trailing PE ratio is 39.66.

PE Ratio	39.66
Forward PE	n/a
PS Ratio	1.15
PB Ratio	2.06
P/TBV Ratio	2.10
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	43.71
EV / Sales	1.27
EV / EBITDA	18.61
EV / EBIT	35.08
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	0.23
Debt / EBITDA	1.86
Debt / FCF	n/a
Interest Coverage	2.40

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	3.34%
Return on Capital Employed (ROCE)	n/a
Revenue Per Employee	4.08M
Profits Per Employee	118,380
Employee Count	363
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -31.30% in the last 52 weeks. The beta is 0.18, so NSE:BAFNAPH's price volatility has been lower than the market average.

Beta (5Y)	0.18
52-Week Price Change	-31.30%
50-Day Moving Average	76.54
200-Day Moving Average	80.00
Relative Strength Index (RSI)	40.24
Average Volume (20 Days)	3,396

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, NSE:BAFNAPH had revenue of INR 1.48 billion and earned 42.97 million in profits. Earnings per share was 1.82.

Revenue	1.48B
Gross Profit	431.35M
Operating Income	53.54M
Pretax Income	42.97M
Net Income	42.97M
EBITDA	100.95M
EBIT	53.54M
Earnings Per Share (EPS)	1.82

Full Income Statement

Balance Sheet

The company has 13.15 million in cash and 188.23 million in debt, giving a net cash position of -175.09 million or -7.40 per share.

Cash & Cash Equivalents	13.15M
Total Debt	188.23M
Net Cash	-175.09M
Net Cash Per Share	-7.40
Equity (Book Value)	827.51M
Book Value Per Share	35.09
Working Capital	n/a

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 29.11%, with operating and profit margins of 3.61% and 2.90%.

Gross Margin	29.11%
Operating Margin	3.61%
Pretax Margin	2.90%
Profit Margin	2.90%
EBITDA Margin	6.81%
EBIT Margin	3.61%
FCF Margin	n/a

Dividends & Yields

NSE:BAFNAPH does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.39%
Shareholder Yield	-0.39%
Earnings Yield	2.52%
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a